FDA, EMA to review Strathspey's DWP-450 for glabellar lines

FDA and EMA each accepted for review applications for DWP-450 from the Alphaeon Corp. subsidiary of Strathspey Crown Holdings LLC (Newport Beach, Calif.) to treat adults with glabellar lines, also known as frown lines between the eyebrows. Alphaeon’s Evolus Inc. unit submitted the BLA to FDA and the MAA to EMA...